Hamza Hashmi, MD
Myeloma Specialist & Cellular Therapist
My Role at MSKWe post reviews for MSK healthcare providers who have at least 30 patient experience surveys completed. If you do not see reviews for a provider, it may be because they do not yet have enough survey responses, or the provider may not be part of the group of healthcare providers included in the survey.
Only outpatient providers are included in the survey. Healthcare providers who only work in the hospital or in urgent care are not included in the survey. Pathologists or researchers who do not provide direct care to patients do not have reviews.
Areas of Expertise
My Specialties
- Chemotherapy
- Immunotherapy
- Chimeric Antigen Receptor (CAR) T-cell Therapy
Request an Appointment
About Me
- Assistant Attending Physician
I am a hematologist-oncologist specializing in the care of people with multiple myeloma and other plasma cell disorders, including:
I see patients with newly-diagnosed and relapsed myeloma (cancer that has come back after treatment). I have expertise in using different types of therapies, including chemotherapy, bone marrow transplant, and chimeric antigen receptor (CAR) T cell therapy, to treat myeloma.
Read more
A blood cancer diagnosis can be life-changing not only for the person with cancer, but also their family. I believe myeloma is not a sprint, but a marathon, and I take great pride in helping my patients at every step of their care journey. Compassion, empathy, competence, and commitment are the core values of my clinical practice. While I share my knowledge and wisdom with my patients and their families, I also rely on them to share their hopes, goals, and preferences for care during the decision-making process. I don’t just listen to their wants and needs — I use them to guide their cancer treatment.
I am excited by the prospect of developing new chemotherapy and immunotherapy treatments, like CAR T cell and bispecific antibodies for multiple myeloma, through clinical trials. In addition to novel therapies, my research centers on developing a better understanding of the interplay of cancer and immunotherapy to overcome treatment resistance in multiple myeloma.
Outside of work, I am an amateur photographer who likes to narrate stories through a camera’s lens.
A myeloma specialist is a doctor with special training in diagnosing and treating myeloma.
A cellular therapy specialist is a doctor with special training in using cell therapies to treat health conditions such as cancer. Therapies can include chimeric antigen receptor (CAR) T cell therapy.
My Specialties
- Chemotherapy
- Immunotherapy
- Chimeric Antigen Receptor (CAR) T-cell Therapy
Education
- MBBS, King Edward Medical University
Residencies
- Internal Medicine, Michigan State University
Awards and Honors
- Top Ten Publishers Club Award, Medical University of South Carolina, (2023)
- Gold Certificate of Excellence, National Cancer Institute Community Oncology Research Program (2023)
- Excellence in Clinical Trial Enrollment Award, Medical University of South Carolina (2023)
- ROYAL Award in Clinical Research, United States Myeloma Innovations Research Collaborative (2023)
Fellowships
- Hematology and Medical Oncology, University of Louisville
- Blood and Marrow Transplantation and Cellular Immunotherapy, H. Lee Moffitt Cancer Center & Research Institute
Board Certifications
- Internal Medicine
- Medical Oncology
- Hematology
Insurance Information
Understanding your insurance options is an important part of managing your cancer care. We have relationships with many common healthcare providers and plans.
In Network Coverage Type
HMO, PPO
In Network Coverage Type
PPO, POS, EPO, HMO
In Network Coverage Type
HMO, EPO PPO, POS
In Network Coverage Type
PPO, POS, EPO, HMO
Offers a qualified health plan from the Health Insurance Marketplace. Call Emblem to learn more.
In Network Coverage Type
PPO, HMO
In Network Coverage Type
PPO, HMO, DSN
In Network Coverage Type
PPO
In Network Coverage Type
HMO, EPO
Offers a qualified health plan from the Health Insurance Marketplace. Call Fidelis to learn more.
In Network Coverage Type
EPO, HMO, PPO, POS
Offers a qualified health plan from the Health Insurance Marketplace. Call Healthfirst to learn more.
In Network Coverage Type
HMO
In Network Coverage Type
PPO
In Network Coverage Type
EPO
In Network Coverage Type
EPO
In Network Coverage Type
Federal Government
In Network Coverage Type
PPO, POS, EPO, HMO
In Network Coverage Type
State Government
Don't see your carrier or plan? We can help you understand your coverage.
If you don't have health insurance or are worried that your care may not be fully covered, our financial assistance programs may be able to help.
If you have questions about insurance, call us at 646-497-9176.
Make an Appointment
New Patients
Current Patients
Contact and Location
Dr. Hashmi sees patients at two locations.
Looking to see a doctor at a different location? See all MSK locations.
Colleagues
Doctors at Memorial Sloan Kettering work as teams, with specialists from all different areas. This allows us to consider all your needs together, and to give you the best possible care.
Clinical Trials
- Clinical Trials Investigated by Dr. Hashmi
- A Phase 2 Study of Iberdomide Maintenance Therapy After Idecabtagene Vicleucel CAR T Therapy for People with Multiple Myeloma
Memorial Sloan Kettering's doctors and scientists are constantly developing new treatments for cancer. MSK is typically running hundreds of clinical trials at a given time.
You may be able to participate in a clinical trial even if you are new to MSK. Search our online directory to find trial information and see more about who can participate.
Search clinical trialsResearch and Publications
Visit PubMed for a full listing of Dr. Hashmi’s journal articles. Pubmed is an online index of research papers and other articles from the US National Library of Medicine and the National Institutes of Health.
See all on PubMedPatient Reviews
Your trust is our main concern
We strive to keep reviews trustworthy, honest and fair. Learn more about our patient experience reviews.
Disclosures
Doctors and faculty members often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community.
MSK requires doctors and faculty members to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public.
Hamza Hashmi discloses the following relationships and financial interests:
-
Amgen
Professional Services and Activities -
Janssen Pharmaceuticals, Inc.
Professional Services and Activities
-
Karyopharm
Professional Services and Activities -
Pfizer, Inc.
Professional Services and Activities
If you’re a patient at MSK and would like more information about your doctor’s external relationships, please talk with your doctor.
The information published here is a complement to other publicly reported data and is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.
This page and data include information for a specific MSK annual disclosure period (January 1, 2023 through disclosure submission in spring 2024). This data reflects interests that may or may not still exist. This data is updated annually.
Learn more about MSK’s COI policies here. For questions regarding MSK’s COI-related policies and procedures, email MSK’s Compliance Office at [email protected].